Review: Akaso 360, the budget alternative for the action cam beginner
Looking for an action cam that can take fish-eye 360° shots but don't have a lot of cash to splash? One option is the Akaso 360 Action Camera aimed at the bu...
Updated 8 min ago · 60 articles from New Atlas
Looking for an action cam that can take fish-eye 360° shots but don't have a lot of cash to splash? One option is the Akaso 360 Action Camera aimed at the bu...
There aren’t many times in my life when I’ve seen a motorcycle command a price tag of over half a million dollars. But then again, there aren’t many motorcyc...
In a particularly vibrant nightlife precinct of Shenzhen, in China, the main attraction may be a massive landlocked cruise ship that's been turned into hotel...
The James Brand launched the original Ellis knife in 2019 as its very first multitool. In fact, it wasn't just any multitool but the brand's own interpretati...
Aotos' Flux X26 cyberpunk-tinged "hybrid" ebike has built on the buzz it generated at CES, raising over US$2.8 million in crowdfunding in a month. As well as...
It is said that during the gold rush, people were so focused on gold that they forgot the “goldmine” that was shovels. In the AI and clean energy boom, where...
Austrian company Tubolito is known for manufacturing bicycle inner tubes from TPU (thermoplastic polyurethane), a high-tech material originally used for smar...
Blackstar has not only crammed a guitar amp into a little box the size of a Bluetooth speaker, but also packed it with high-tech features to get a vast array...
Audi has built a new V16-engined multi-million-dollar mid-engined supercar… but it looks like a version of the Batmobile made by an eccentric backwoods mecha...
Google's just launched the Fitbit Air, a screenless wearable that slips onto your wrist to track your fitness activities, sleep, and other health stats. It's...
The battery has long been the weak link of the electric bike. It degrades in the cold, ages poorly with fast charging, and rarely survives more than four yea...
It's long been thought that the type-2 diabetes drug taken by an estimated 20 million Americans was doing its heavy lifting in the liver, suppressing the pro...